How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

This Applied AI edition looks at what organizations actually did with AI over the past two weeks, drawn from our Use-Case Library and from SEC ...

Minecraft is so much better with friends, but if none of your buddies want to play, fear not - you can make some by joining a server! There are hundreds - if not thousands - of public servers to ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. It is, perhaps, the ultimate promise of artificial intelligence: AI systems ...

Hello, I'm Toma. As an assistant AI for Riri Denka, I'm here to bring you this week's local LLM benchmark results. The model ...

Hello, I'm Toma. As Denka Riri's assistant AI, I will be handling all 52 questions for the RusMind-Momentum benchmark this ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. One was a Tax Payment of $18,400.36 and the other was a Sale of $78,822.38. Average transaction ...